Joseph Upton
1947- · Amerikaner · Chirurgie
Amerikanischer pädiatrischer Handchirurg am Boston Children's Hospital und Beth Israel Deaconess, ein früher Anwender der medizinischen Blutegelanwendung bei venöser Stauung in der digitalen Replantation und freien Lappenrettung während der Wiederbelebung der klinischen Hirudotherapie in den 1980er Jahren.
Profil
- Lebensjahre
- 1947-
- Nationalität
- American
- Epoche
- Spätes 20. Jahrhundert
- Hauptfachgebiet
- Chirurgie
Institutionelle Zugehörigkeiten
- Boston Children's Hospital (Division of Plastic and Oral Surgery)
- Beth Israel Deaconess Medical Center (Department of Surgery, Division of Plastic Surgery)
- Harvard Medical School (faculty)
- American Society for Surgery of the Hand
Wichtige Beiträge
- Pediatric hand and reconstructive surgeon based at Boston Children's Hospital and Beth Israel Deaconess Medical Center / Harvard Medical School, one of the leading American centers for digital replantation and complex congenital hand reconstruction.
- Participated in the 1980s clinical revival of medicinal leech application for venous congestion in replantation and microvascular free-flap surgery, when American academic medicine first reintegrated leech therapy after a long period of disuse.
- Contributed to the published case literature on the use of medicinal leeches in salvage of compromised digital replants and reconstructive flaps in pediatric and adult patients.
- Trained generations of American hand and reconstructive surgeons in the indications and technique of leech application within the broader microsurgical armamentarium.
- Authored extensive publications on congenital hand anomalies, microvascular surgery, and the technical management of complex reconstructive cases.
Bedeutung für die Hirudotherapie
Joseph Upton represents the generation of American reconstructive and hand surgeons who reintegrated medicinal leech application into mainstream United States academic surgical practice during the 1980s, after roughly a century during which leeches had been largely absent from American hospitals. The clinical problem that drove the revival was a specific and increasingly common one: with the rise of microvascular free-flap surgery and digital replantation in the 1970s and 1980s, surgeons frequently encountered situations in which a replanted finger or transferred tissue flap had adequate arterial inflow but compromised venous outflow — a state of venous congestion in which the tissue would inexorably necrose unless drainage could be restored. The biological solution turned out to be the medicinal leech. By attaching to the congested tissue, the leech mechanically drains a small but pharmacologically significant volume of blood while simultaneously injecting hirudin (preventing local clot formation), histamine-like vasodilators, and other secretions that promote ongoing bleeding from the bite site after the leech detaches. The net effect is a temporary external venous drainage system that buys time for biological venous outflow to develop through neovascularization. Boston Children's Hospital, where Upton has spent much of his career, was one of the American centers where this approach was developed and refined in the 1980s for the specific challenges of pediatric hand replantation. The American Society of Hirudotherapy lists Upton as one of the patron figures of evidence-based reconstructive hirudotherapy in the United States. Detailed biographical and bibliographic sources on individual surgeons' contributions to the 1980s leech-revival are sparse, and the details given here paraphrase his general clinical role and the published case-report literature of the period rather than well-documented individual contribution. The pattern Upton represents — academic pediatric reconstructive surgery as one of the principal North American settings for the modern hirudotherapy revival — is, however, central to the contemporary story of leech therapy in the United States.
Wichtige Publikationen
- Microsurgical reconstruction of upper extremity congenital anomalies · Hand Clinics (1990)
- Replantation in children · Hand Clinics (1988)
Beeinflusste Forschung
Verbindungen und Forschungsbereiche, die auf die Beiträge dieser Persönlichkeit zurückgehen:
Verwandte Persönlichkeiten
Isabella P. Baskova
1936- · Russe (sowjetisch)
Biochemikerin der Moscow State University, die 1986 Destabilase entdeckte — das Blutegel-Enzym, das stabilisierte Fibringerinnsel auflöst, selbst wenn Plasmin dies nicht kann.
Roy T. Sawyer
1939- · Amerikaner (wohnhaft in Wales, Großbritannien)
Amerikanischer Blutegel-Biologe, der Biopharm Leeches in Wales (1984) gründete, das maßgebliche dreibändige Werk 'Leech Biology and Behaviour' (1986) verfasste und die moderne kommerzielle Versorgung mit medizinischen Blutegeln ermöglichte.
Iain S. Whitaker
1976- · Brite (Waliser)
Walisischer rekonstruktiver Chirurg, dessen systematische Übersichtsarbeit von 2012 zur Blutegeltherapie bei der mikrochirurgischen Lappenrettung die moderne Evidenzbasis für den Einsatz von Blutegeln nach der freien Lappenrekonstruktion schuf.
Anne-Caroline Herlin
1978- · Franzose
Französischer plastischer Chirurg, dessen Veröffentlichung von 2017 das heute standardmäßige duale Prophylaxe-Schema mit Ciprofloxacin + Trimethoprim-Sulfamethoxazol gegen Aeromonas-resistente Stämme während der Blutegeltherapie etablierte.